Ibuprofene Bambini Gusto Fragola Senza Zucchero Docgen

Ibuprofen, the active ingredient in Ibuprofene Bambini Gusto Fragola Senza Zucchero Docgen, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral liquid formulation for pediatric use. It is used to relieve pain, reduce fever, and lessen inflammation in children.

GNH USA supplies Ibuprofene Bambini Gusto Fragola Senza Zucchero Docgen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibuprofen acts as an analgesic, antipyretic and anti‑inflammatory agent in the pediatric population. - Pain relief: reduces mild to moderate pain associated with common childhood conditions. - Fever reduction: lowers elevated body temperature in febrile illnesses. - Inflammation: alleviates inflammatory swelling such as that seen in minor injuries or dental pain.

Adverse reactions may occur with ibuprofen use in children.

Common Side Effects: - Stomach upset or dyspepsia - Nausea - Vomiting - Mild skin rash - Headache - Dizziness

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe allergic reactions including anaphylaxis - Elevated liver enzymes or hepatic injury - Stevens‑Johnson syndrome or toxic epidermal necrolysis

When using ibuprofen in children, several safety considerations apply. - Age restriction: not recommended for infants under 3 months without medical supervision. - Weight‑based dosing: dose must be calculated according to the child’s weight. - Hypersensitivity: avoid if the child has known allergy to ibuprofen or other NSAIDs. - Asthma caution: monitor for bronchospasm in children with a history of asthma. - Renal function: use with caution in children with impaired kidney function. - Store at ambient temperature: keep below 25 °C, retain in the original container, and protect from moisture.

Ibuprofen can interact with several medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Corticosteroids: additive ulcer risk. - Lithium: possible increase in lithium levels. - Methotrexate: reduced clearance leading to toxicity.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: may reduce renal perfusion. - Diuretics: potential for decreased kidney function. - Selective serotonin reuptake inhibitors (SSRIs): modest increase in bleeding tendency. - Antihypertensives: possible attenuation of blood‑pressure‑lowering effect. - Beta‑blockers: monitor for altered hemodynamics.